Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA d... ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.1603 | 11.8302583026 | 1.355 | 1.66 | 1.3301 | 1926605 | 1.53061417 | CS |
| 4 | -0.1141 | -7.00257763594 | 1.6294 | 1.7461 | 1.315 | 1816275 | 1.49529327 | CS |
| 12 | -0.1247 | -7.60365853659 | 1.64 | 2.565 | 1.3 | 2876851 | 1.90822905 | CS |
| 26 | 0.3253 | 27.3361344538 | 1.19 | 2.565 | 1.03 | 2087879 | 1.72999856 | CS |
| 52 | -0.2897 | -16.0498614958 | 1.805 | 2.85 | 1.03 | 1531292 | 1.75244616 | CS |
| 156 | -3.6247 | -70.5194552529 | 5.14 | 5.6 | 1.025 | 1188155 | 2.11876763 | CS |
| 260 | -0.3147 | -17.1967213115 | 1.83 | 22.91 | 1.025 | 919121 | 3.22498182 | CS |
| Nessuna Discussione Trovata |
| Crea Discussione |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
